Crossmark

Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells

Crossref DOI link: https://doi.org/10.1038/s41417-018-0040-3

Published Online: 2018-08-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Biao

Ma, Yan-Bin

Chu, Sheng-Hua
License Information

Text and Data Mining valid from 2018-08-24
More Information

Article History

Received: 11 January 2018

Revised: 2 July 2018

Accepted: 7 July 2018

First Online: 24 August 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.